Marella Thorell's Insider Trades & SAST Disclosures
Marella Thorell's most recent trade in Seres Therapeutics Inc was a trade of 650,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Marella Thorell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Marella Thorell | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Carisma Therapeutics Inc | Marella Thorell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 38,700 | 38,700 | - | - | Stock Option (Right to Buy) | |
| Essa Pharma Inc | Marella Thorell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 50,000 | 50,000 | - | - | Options | |
| Evelo Biosciences Inc | Marella Thorell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 6,500 | 13,000 | - | - | Restricted Stock Units | |
| Evelo Biosciences Inc | Marella Thorell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 6,500 | 11,073 (0%) | 0% | - | Common Stock | |
| Evelo Biosciences Inc | Marella Thorell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.51 per share. | 07 Aug 2023 | 2,004 | 9,069 (0%) | 0% | 9.5 | 19,058 | Common Stock |
| Evelo Biosciences Inc | Marella Thorell | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.13 per share. | 08 May 2023 | 38,531 | 91,469 (0%) | 0% | 0.1 | 4,836 | Common Stock |
| Evelo Biosciences Inc | Marella Thorell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 130,000 | 390,000 | - | - | Restricted Stock Units | |
| Evelo Biosciences Inc | Marella Thorell | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 130,000 | 130,000 (0%) | 0% | - | Common Stock | |
| Evelo Biosciences Inc | Marella Thorell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 520,000 | 520,000 | - | - | Restricted Stock Units | |
| Essa Pharma Inc | Marella Thorell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges